ARQT and PVLA Related Headlines

Go Back

Apr 7, 2026 12:26PM Palvella Therapeutics names Kent Taylor sales chief
Apr 7, 2026 07:30AM Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Sep 3, 2025 07:30AM Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer

ARQT and PVLA Related Press Releases

Go Back

Apr 7, 2026 07:30AM Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
Sep 3, 2025 07:30AM Palvella Therapeutics Strengthens Leadership with Appointment of Accomplished Scientist and Biopharmaceutical Executive David W. Osborne, Ph.D. as Chief Innovation Officer

ARQT and PVLA Related SEC Filings

Go Back